Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
Canada
Factor viii inhibitor bypassing activity

Health Canada

Factor viii inhibitor bypassing activity

Feiba NF

650 UNIT / VIAL Kit, Powder For SolutionCanadaAuthorised

Open in the registerAsk Osler about it

On this page

In other countries
Documents
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

Feiba 100 U/ml prašak i otapalo za otopinu za infuzijuCroatia · Prašak i otapalo za otopinu za infuziju · Baxalta Innovations GmbH, Industriestrasse 67, Beč, AustrijaSame brand
Feiba 50 U/ml prašak i otapalo za otopinu za infuzijuCroatia · prašak i otapalo za otopinu za infuziju · Baxalta Innovations GmbH, Industriestrasse 67, Beč, AustrijaSame brand
FeibaItaly · Polvere e solvente per soluzione iniettabile · Baxalta Innovations GMBHSame brand
FEIBA 100 E/ml, poeder en oplosmiddel voor oplossing voor infusieNetherlands · Poeder en oplosmiddel voor oplossing voor infusie · Baxalta Innovations GmbHSame brand
FEIBA 25 U/mlRomania · 25U/ml · pulb+solv. pt. sol. perf. · Baxalta Innovations GMBHSame brand
FEIBA 50 U/mlRomania · 50U/ml · pulb+solv. pt. sol. perf. · Baxalta Innovations GMBH

More with the same substance on this register

Feiba NFFactor viii inhibitor bypassing activity · 1300 UNIT / VIAL · Kit, Powder For SolutionCanada
Feiba NFFactor viii inhibitor bypassing activity · 3250 UNIT / VIAL · Kit, Powder For SolutionCanada

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Same brand

🇷🇸Feiba NFSerbia · 500j./20mL · prašak i rastvarač za rastvor za infuziju · Takeda DOOSame brand

🇸🇦Feiba 50U Powder&SolventSaudi Arabia · Takeda Manufacturing Austria AGSame brand

🇸🇦Feiba 50U Powder&SolventSaudi Arabia · Baxter AGSame brand

🇸🇬Feiba 1000 USingapore · 50 u/ml · injection, powder, for solution · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.Same brand

🇸🇬Feiba 500 USingapore · 25 u/ml · injection, powder, for solution · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.Same brand

🇭🇷octaplasLG 45-70 mg/ml otopina za infuzijuCroatia · otopina za infuziju · Octapharma (IP) SPRL, Allee De La Recherche 65, Anderlecht, BelgijaSame substance

🇺🇸Autoplex, Feiba Nf, Feiba VhUnited States · 500U · For Injection · Takeda Pharmaceuticals U.S.A., Inc.Same substance

🇺🇸Autoplex, Feiba Nf, Feiba VhUnited States · 1000U · For Injection · Takeda Pharmaceuticals U.S.A., Inc.Same substance

🇺🇸Autoplex, Feiba Nf, Feiba VhUnited States · 2500U · For Injection · Takeda Pharmaceuticals U.S.A., Inc.Same substance

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Factor viii inhibitor bypassing activity
Strength: 650 UNIT / VIAL
Dosage form: Kit, Powder For Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Authorised
Status in the register: Approved
Registration: DIN 02489600
Marketing authorisation holder: Takeda Canada INC
ATC code: B02BD03
Group: Blood and blood-forming organs
Supply: SCHEDULE D

Health CanadaFeiba NFFactor viii inhibitor bypassing activity · 650 UNIT / VIAL · Kit, Powder For Solution🇨🇦CanadaCancelled